Nexstim Oyj
Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's transcranial magnetic stimulation (TMS) is a non-invasive neuromodulation technique whereby pulses of electromagnetic fields target and interact with specific brain regions from outside the head. It provi… Read more
Nexstim Oyj (NXTMH) - Total Liabilities
Latest total liabilities as of June 2025: €9.17 Million EUR
Based on the latest financial reports, Nexstim Oyj (NXTMH) has total liabilities worth €9.17 Million EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Nexstim Oyj - Total Liabilities Trend (2012–2024)
This chart illustrates how Nexstim Oyj's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Nexstim Oyj Competitors by Total Liabilities
The table below lists competitors of Nexstim Oyj ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kangyue Technology Co Ltd
SHE:300391
|
China | CN¥2.59 Billion |
|
Hektar Real Estate Investment Trust
KLSE:5121
|
Malaysia | RM707.97 Million |
|
Kezar Life Sciences Inc
NASDAQ:KZR
|
USA | $14.75 Million |
|
Kumho HT Inc
KO:214330
|
Korea | ₩119.57 Billion |
|
Synthaverse S.A.
WAR:SVE
|
Poland | zł177.72 Million |
|
KLEA HOLDING
PA:ALKLH
|
France | €10.00 Million |
|
Natuzzi SpA
NYSE:NTZ
|
USA | $248.90 Million |
|
OTRS AG
F:TR9
|
Germany | €7.20 Million |
Liability Composition Analysis (2012–2024)
This chart breaks down Nexstim Oyj's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.25 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.88 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.74 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nexstim Oyj's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nexstim Oyj (2012–2024)
The table below shows the annual total liabilities of Nexstim Oyj from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €10.50 Million | +49.04% |
| 2023-12-31 | €7.05 Million | +14.66% |
| 2022-12-31 | €6.15 Million | -10.11% |
| 2021-12-31 | €6.84 Million | -11.21% |
| 2020-12-31 | €7.70 Million | -8.27% |
| 2019-12-31 | €8.39 Million | -15.68% |
| 2018-12-31 | €9.96 Million | +80.27% |
| 2017-12-31 | €5.52 Million | -7.00% |
| 2016-12-31 | €5.94 Million | +4.90% |
| 2015-12-31 | €5.66 Million | +4.76% |
| 2014-12-31 | €5.40 Million | -0.47% |
| 2013-12-31 | €5.43 Million | +48.42% |
| 2012-12-31 | €3.66 Million | -- |